BRAF and melanoma: Although we consider the broad gene panel tests using RT-PCR, MALDI-TOF, and NGS techniques to be the gold standard for reflex testing in melanoma, we acknowledge the cost-effective rationale of several Canadian institutions employing immunohistochemistry using BRAF VE1 monoclonal antibody to assess for BRAF V600E mutation prior to initiating molecular testing.